Skip to main content
Premium Trial:

Request an Annual Quote

Ag Genomics: Monsanto Closes Cereon, Keeps Millennium Partnership


Cereon Genomics, a wholly owned subsidiary of Monsanto and a product of a long-term collaboration with Millennium Pharmaceuticals, has been shut down. The Cambridge, Mass., facility, home to approximately 140 employees, “will not be part of our system around mid-year,” says Monsanto spokeswoman Lori Fisher.

The decision coincides with a restructuring plan underway at Monsanto, which will cost as much as $124 million and would cut about five percent of its worldwide staff — between 600 and 700, the majority of which would be in New Zealand, southeastern Asia, Australia, and North America, Fisher says. Some of the Cereon staff will assume positions within Monsanto, but she could not say how many.

“It’s a tough decision,” Fisher says. “Cereon has been extraordinarily successful … in structural and functional genomics.”

Fisher stressed that the decision to shut down Cereon, which was launched in 1997, has not affected Monsanto’s broader collaboration with Millennium. Monsanto also has ongoing relationships with Affymetrix, Bangalore Genomics, Ceres, danforth plant sciences Center, IBM, Incyte, Mystic Genomics, Orchid BioSciences, Paradigm, Rosetta, and Third Wave Technologies.

— Kirell Lakhman


The Scan

Interfering With Invasive Mussels

The Chicago Tribune reports that researchers are studying whether RNA interference- or CRISPR-based approaches can combat invasive freshwater mussels.

Participation Analysis

A new study finds that women tend to participate less at scientific meetings but that some changes can lead to increased involvement, the Guardian reports.

Right Whales' Decline

A research study plans to use genetic analysis to gain insight into population decline among North American right whales, according to CBC.

Science Papers Tie Rare Mutations to Short Stature, Immunodeficiency; Present Single-Cell Transcriptomics Map

In Science this week: pair of mutations in one gene uncovered in brothers with short stature and immunodeficiency, and more.